NCT02631876 · Interventional trial
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer
Overall registry status Completed
Phase 3
Conditions Epithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma
Delaware Valley sites
- MD Anderson Cancer Center - Cooper Health · Camden, NJ · Camden County
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory